Global Subcutaneous Allergy Immunotherapies Market Insights and Forecast to 2027

世界の皮下アレルギー免疫療法市場インサイト・予測(~2027)

◆タイトル:Global Subcutaneous Allergy Immunotherapies Market Insights and Forecast to 2027
◆商品コード:QYR21DC05573
◆調査・発行会社:QYResearch
◆発行日:2021年11月
◆ページ数:102
◆レポート形式:(印刷可能)PDF / 英語
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥563,500見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥845,250見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,127,000見積依頼/購入/質問フォーム
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常2日~3日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearchの日本における正規販売代理店です。

【レポートの概要】

本調査レポートは皮下アレルギー免疫療法の世界市場の現状について調査・分析し、2027年までの市場を予測しました。皮下アレルギー免疫療法の世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模(高濃度、低濃度)、用途別市場規模(原発性免疫不全症、二次性免疫不全症、その他)、主要地域別市場規模(北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ)、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。

・皮下アレルギー免疫療法の世界市場概要
・メーカー別の競争状況、市場シェア
・皮下アレルギー免疫療法の種類別市場規模:高濃度、低濃度
・皮下アレルギー免疫療法の用途別市場規模:原発性免疫不全症、二次性免疫不全症、その他
・北米の皮下アレルギー免疫療法市場規模2016-2027:種類別、用途別、国別(アメリカ、カナダ)
・ヨーロッパの皮下アレルギー免疫療法市場規模2016-2027:種類別、用途別、国別(ドイツ、フランス、イギリス)
・アジアの皮下アレルギー免疫療法市場規模2016-2027:種類別、用途別、国別(日本、中国、インド、韓国)
・中南米の皮下アレルギー免疫療法市場規模2016-2027:種類別、用途別、国別(メキシコ、ブラジル)
・中東・アフリカの皮下アレルギー免疫療法市場規模2016-2027:種類別、用途別、国別(トルコ、サウジアラビア)
・企業情報:ALK-Abello、Stallergenes Greer、Merck、Allergy Therapeutics、HAL、WOLW Pharma、Holister Stier、Leti
・皮下アレルギー免疫療法のバリューチェーン・販売チャネル分析
・皮下アレルギー免疫療法の世界市場動向

Allergen immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment for some types of allergies. It is useful for environmental allergies, allergies to insect bites, and asthma. Its benefit for food allergies is unclear and thus not recommended. Immunotherapy involves exposing people to larger and larger amounts of allergen in an attempt to change the immune system’s response.

Market Analysis and Insights: Global Subcutaneous Allergy Immunotherapies Market
The global Subcutaneous Allergy Immunotherapies market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.

Global Subcutaneous Allergy Immunotherapies Scope and Segment
Subcutaneous Allergy Immunotherapies market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Subcutaneous Allergy Immunotherapies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
High Concentration
Low Concentration

Segment by Application
Primary Immunodeficiency
Secondary Immunodeficiency
Others

By Company
ALK-Abello
Stallergenes Greer
Merck
Allergy Therapeutics
HAL
WOLW Pharma
Holister Stier
Leti

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

【レポートの目次】

1 Study Coverage
1.1 Subcutaneous Allergy Immunotherapies Product Introduction
1.2 Market by Type
1.2.1 Global Subcutaneous Allergy Immunotherapies Market Size Growth Rate by Type
1.2.2 High Concentration
1.2.3 Low Concentration
1.3 Market by Application
1.3.1 Global Subcutaneous Allergy Immunotherapies Market Size Growth Rate by Application
1.3.2 Primary Immunodeficiency
1.3.3 Secondary Immunodeficiency
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Subcutaneous Allergy Immunotherapies Sales Estimates and Forecasts 2016-2027
2.2 Global Subcutaneous Allergy Immunotherapies Revenue Estimates and Forecasts 2016-2027
2.3 Global Subcutaneous Allergy Immunotherapies Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Subcutaneous Allergy Immunotherapies Regions by Sales
2.4.1 Global Top Subcutaneous Allergy Immunotherapies Regions by Sales (2016-2021)
2.4.2 Global Top Subcutaneous Allergy Immunotherapies Regions by Sales (2022-2027)
2.5 Global Top Subcutaneous Allergy Immunotherapies Regions by Revenue
2.5.1 Global Top Subcutaneous Allergy Immunotherapies Regions by Revenue (2016-2021)
2.5.2 Global Top Subcutaneous Allergy Immunotherapies Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa

3 Competition by Manufacturers
3.1 Global Subcutaneous Allergy Immunotherapies Sales by Manufacturers
3.1.1 Global Top Subcutaneous Allergy Immunotherapies Manufacturers by Sales (2016-2021)
3.1.2 Global Top Subcutaneous Allergy Immunotherapies Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Subcutaneous Allergy Immunotherapies Sales in 2020
3.2 Global Subcutaneous Allergy Immunotherapies Revenue by Manufacturers
3.2.1 Global Top Subcutaneous Allergy Immunotherapies Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Subcutaneous Allergy Immunotherapies Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Subcutaneous Allergy Immunotherapies Revenue in 2020
3.3 Global Subcutaneous Allergy Immunotherapies Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Subcutaneous Allergy Immunotherapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Subcutaneous Allergy Immunotherapies Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Subcutaneous Allergy Immunotherapies Sales by Type
4.1.1 Global Subcutaneous Allergy Immunotherapies Historical Sales by Type (2016-2021)
4.1.2 Global Subcutaneous Allergy Immunotherapies Forecasted Sales by Type (2022-2027)
4.1.3 Global Subcutaneous Allergy Immunotherapies Sales Market Share by Type (2016-2027)
4.2 Global Subcutaneous Allergy Immunotherapies Revenue by Type
4.2.1 Global Subcutaneous Allergy Immunotherapies Historical Revenue by Type (2016-2021)
4.2.2 Global Subcutaneous Allergy Immunotherapies Forecasted Revenue by Type (2022-2027)
4.2.3 Global Subcutaneous Allergy Immunotherapies Revenue Market Share by Type (2016-2027)
4.3 Global Subcutaneous Allergy Immunotherapies Price by Type
4.3.1 Global Subcutaneous Allergy Immunotherapies Price by Type (2016-2021)
4.3.2 Global Subcutaneous Allergy Immunotherapies Price Forecast by Type (2022-2027)

5 Market Size by Application
5.1 Global Subcutaneous Allergy Immunotherapies Sales by Application
5.1.1 Global Subcutaneous Allergy Immunotherapies Historical Sales by Application (2016-2021)
5.1.2 Global Subcutaneous Allergy Immunotherapies Forecasted Sales by Application (2022-2027)
5.1.3 Global Subcutaneous Allergy Immunotherapies Sales Market Share by Application (2016-2027)
5.2 Global Subcutaneous Allergy Immunotherapies Revenue by Application
5.2.1 Global Subcutaneous Allergy Immunotherapies Historical Revenue by Application (2016-2021)
5.2.2 Global Subcutaneous Allergy Immunotherapies Forecasted Revenue by Application (2022-2027)
5.2.3 Global Subcutaneous Allergy Immunotherapies Revenue Market Share by Application (2016-2027)
5.3 Global Subcutaneous Allergy Immunotherapies Price by Application
5.3.1 Global Subcutaneous Allergy Immunotherapies Price by Application (2016-2021)
5.3.2 Global Subcutaneous Allergy Immunotherapies Price Forecast by Application (2022-2027)

6 North America
6.1 North America Subcutaneous Allergy Immunotherapies Market Size by Type
6.1.1 North America Subcutaneous Allergy Immunotherapies Sales by Type (2016-2027)
6.1.2 North America Subcutaneous Allergy Immunotherapies Revenue by Type (2016-2027)
6.2 North America Subcutaneous Allergy Immunotherapies Market Size by Application
6.2.1 North America Subcutaneous Allergy Immunotherapies Sales by Application (2016-2027)
6.2.2 North America Subcutaneous Allergy Immunotherapies Revenue by Application (2016-2027)
6.3 North America Subcutaneous Allergy Immunotherapies Market Size by Country
6.3.1 North America Subcutaneous Allergy Immunotherapies Sales by Country (2016-2027)
6.3.2 North America Subcutaneous Allergy Immunotherapies Revenue by Country (2016-2027)
6.3.3 United States
6.3.4 Canada

7 Europe
7.1 Europe Subcutaneous Allergy Immunotherapies Market Size by Type
7.1.1 Europe Subcutaneous Allergy Immunotherapies Sales by Type (2016-2027)
7.1.2 Europe Subcutaneous Allergy Immunotherapies Revenue by Type (2016-2027)
7.2 Europe Subcutaneous Allergy Immunotherapies Market Size by Application
7.2.1 Europe Subcutaneous Allergy Immunotherapies Sales by Application (2016-2027)
7.2.2 Europe Subcutaneous Allergy Immunotherapies Revenue by Application (2016-2027)
7.3 Europe Subcutaneous Allergy Immunotherapies Market Size by Country
7.3.1 Europe Subcutaneous Allergy Immunotherapies Sales by Country (2016-2027)
7.3.2 Europe Subcutaneous Allergy Immunotherapies Revenue by Country (2016-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia

8 Asia Pacific
8.1 Asia Pacific Subcutaneous Allergy Immunotherapies Market Size by Type
8.1.1 Asia Pacific Subcutaneous Allergy Immunotherapies Sales by Type (2016-2027)
8.1.2 Asia Pacific Subcutaneous Allergy Immunotherapies Revenue by Type (2016-2027)
8.2 Asia Pacific Subcutaneous Allergy Immunotherapies Market Size by Application
8.2.1 Asia Pacific Subcutaneous Allergy Immunotherapies Sales by Application (2016-2027)
8.2.2 Asia Pacific Subcutaneous Allergy Immunotherapies Revenue by Application (2016-2027)
8.3 Asia Pacific Subcutaneous Allergy Immunotherapies Market Size by Region
8.3.1 Asia Pacific Subcutaneous Allergy Immunotherapies Sales by Region (2016-2027)
8.3.2 Asia Pacific Subcutaneous Allergy Immunotherapies Revenue by Region (2016-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia

9 Latin America
9.1 Latin America Subcutaneous Allergy Immunotherapies Market Size by Type
9.1.1 Latin America Subcutaneous Allergy Immunotherapies Sales by Type (2016-2027)
9.1.2 Latin America Subcutaneous Allergy Immunotherapies Revenue by Type (2016-2027)
9.2 Latin America Subcutaneous Allergy Immunotherapies Market Size by Application
9.2.1 Latin America Subcutaneous Allergy Immunotherapies Sales by Application (2016-2027)
9.2.2 Latin America Subcutaneous Allergy Immunotherapies Revenue by Application (2016-2027)
9.3 Latin America Subcutaneous Allergy Immunotherapies Market Size by Country
9.3.1 Latin America Subcutaneous Allergy Immunotherapies Sales by Country (2016-2027)
9.3.2 Latin America Subcutaneous Allergy Immunotherapies Revenue by Country (2016-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia

10 Middle East and Africa
10.1 Middle East and Africa Subcutaneous Allergy Immunotherapies Market Size by Type
10.1.1 Middle East and Africa Subcutaneous Allergy Immunotherapies Sales by Type (2016-2027)
10.1.2 Middle East and Africa Subcutaneous Allergy Immunotherapies Revenue by Type (2016-2027)
10.2 Middle East and Africa Subcutaneous Allergy Immunotherapies Market Size by Application
10.2.1 Middle East and Africa Subcutaneous Allergy Immunotherapies Sales by Application (2016-2027)
10.2.2 Middle East and Africa Subcutaneous Allergy Immunotherapies Revenue by Application (2016-2027)
10.3 Middle East and Africa Subcutaneous Allergy Immunotherapies Market Size by Country
10.3.1 Middle East and Africa Subcutaneous Allergy Immunotherapies Sales by Country (2016-2027)
10.3.2 Middle East and Africa Subcutaneous Allergy Immunotherapies Revenue by Country (2016-2027)
10.3.3 Turkey
10.3.4 Saudi Arabia

11 Company Profiles
11.1 ALK-Abello
11.1.1 ALK-Abello Corporation Information
11.1.2 ALK-Abello Overview
11.1.3 ALK-Abello Subcutaneous Allergy Immunotherapies Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 ALK-Abello Subcutaneous Allergy Immunotherapies Product Description
11.1.5 ALK-Abello Recent Developments
11.2 Stallergenes Greer
11.2.1 Stallergenes Greer Corporation Information
11.2.2 Stallergenes Greer Overview
11.2.3 Stallergenes Greer Subcutaneous Allergy Immunotherapies Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Stallergenes Greer Subcutaneous Allergy Immunotherapies Product Description
11.2.5 Stallergenes Greer Recent Developments
11.3 Merck
11.3.1 Merck Corporation Information
11.3.2 Merck Overview
11.3.3 Merck Subcutaneous Allergy Immunotherapies Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Merck Subcutaneous Allergy Immunotherapies Product Description
11.3.5 Merck Recent Developments
11.4 Allergy Therapeutics
11.4.1 Allergy Therapeutics Corporation Information
11.4.2 Allergy Therapeutics Overview
11.4.3 Allergy Therapeutics Subcutaneous Allergy Immunotherapies Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Allergy Therapeutics Subcutaneous Allergy Immunotherapies Product Description
11.4.5 Allergy Therapeutics Recent Developments
11.5 HAL
11.5.1 HAL Corporation Information
11.5.2 HAL Overview
11.5.3 HAL Subcutaneous Allergy Immunotherapies Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 HAL Subcutaneous Allergy Immunotherapies Product Description
11.5.5 HAL Recent Developments
11.6 WOLW Pharma
11.6.1 WOLW Pharma Corporation Information
11.6.2 WOLW Pharma Overview
11.6.3 WOLW Pharma Subcutaneous Allergy Immunotherapies Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 WOLW Pharma Subcutaneous Allergy Immunotherapies Product Description
11.6.5 WOLW Pharma Recent Developments
11.7 Holister Stier
11.7.1 Holister Stier Corporation Information
11.7.2 Holister Stier Overview
11.7.3 Holister Stier Subcutaneous Allergy Immunotherapies Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 Holister Stier Subcutaneous Allergy Immunotherapies Product Description
11.7.5 Holister Stier Recent Developments
11.8 Leti
11.8.1 Leti Corporation Information
11.8.2 Leti Overview
11.8.3 Leti Subcutaneous Allergy Immunotherapies Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 Leti Subcutaneous Allergy Immunotherapies Product Description
11.8.5 Leti Recent Developments

12 Value Chain and Sales Channels Analysis
12.1 Subcutaneous Allergy Immunotherapies Value Chain Analysis
12.2 Subcutaneous Allergy Immunotherapies Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Subcutaneous Allergy Immunotherapies Production Mode & Process
12.4 Subcutaneous Allergy Immunotherapies Sales and Marketing
12.4.1 Subcutaneous Allergy Immunotherapies Sales Channels
12.4.2 Subcutaneous Allergy Immunotherapies Distributors
12.5 Subcutaneous Allergy Immunotherapies Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Subcutaneous Allergy Immunotherapies Industry Trends
13.2 Subcutaneous Allergy Immunotherapies Market Drivers
13.3 Subcutaneous Allergy Immunotherapies Market Challenges
13.4 Subcutaneous Allergy Immunotherapies Market Restraints

14 Key Findings in The Global Subcutaneous Allergy Immunotherapies Study

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Subcutaneous Allergy Immunotherapies Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of High Concentration
Table 3. Major Manufacturers of Low Concentration
Table 4. Global Subcutaneous Allergy Immunotherapies Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 5. Global Subcutaneous Allergy Immunotherapies Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 6. Global Subcutaneous Allergy Immunotherapies Sales by Region (2016-2021) & (K Units)
Table 7. Global Subcutaneous Allergy Immunotherapies Sales Market Share by Region (2016-2021)
Table 8. Global Subcutaneous Allergy Immunotherapies Sales by Region (2022-2027) & (K Units)
Table 9. Global Subcutaneous Allergy Immunotherapies Sales Market Share by Region (2022-2027)
Table 10. Global Subcutaneous Allergy Immunotherapies Revenue by Region (2016-2021) & (US$ Million)
Table 11. Global Subcutaneous Allergy Immunotherapies Revenue Market Share by Region (2016-2021)
Table 12. Global Subcutaneous Allergy Immunotherapies Revenue by Region (2022-2027) & (US$ Million)
Table 13. Global Subcutaneous Allergy Immunotherapies Revenue Market Share by Region (2022-2027)
Table 14. Global Subcutaneous Allergy Immunotherapies Sales by Manufacturers (2016-2021) & (K Units)
Table 15. Global Subcutaneous Allergy Immunotherapies Sales Share by Manufacturers (2016-2021)
Table 16. Global Subcutaneous Allergy Immunotherapies Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 17. Global Subcutaneous Allergy Immunotherapies Revenue Share by Manufacturers (2016-2021)
Table 18. Subcutaneous Allergy Immunotherapies Price by Manufacturers 2016-2021 (US$/Unit)
Table 19. Global Subcutaneous Allergy Immunotherapies Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Subcutaneous Allergy Immunotherapies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Subcutaneous Allergy Immunotherapies as of 2020)
Table 21. Subcutaneous Allergy Immunotherapies Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Subcutaneous Allergy Immunotherapies Product Offered
Table 23. Date of Manufacturers Enter into Subcutaneous Allergy Immunotherapies Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Subcutaneous Allergy Immunotherapies Sales by Type (2016-2021) & (K Units)
Table 26. Global Subcutaneous Allergy Immunotherapies Sales by Type (2022-2027) & (K Units)
Table 27. Global Subcutaneous Allergy Immunotherapies Sales Share by Type (2016-2021)
Table 28. Global Subcutaneous Allergy Immunotherapies Sales Share by Type (2022-2027)
Table 29. Global Subcutaneous Allergy Immunotherapies Revenue by Type (2016-2021) & (US$ Million)
Table 30. Global Subcutaneous Allergy Immunotherapies Revenue by Type (2022-2027) & (US$ Million)
Table 31. Global Subcutaneous Allergy Immunotherapies Revenue Share by Type (2016-2021)
Table 32. Global Subcutaneous Allergy Immunotherapies Revenue Share by Type (2022-2027)
Table 33. Subcutaneous Allergy Immunotherapies Price by Type (2016-2021) & (US$/Unit)
Table 34. Global Subcutaneous Allergy Immunotherapies Price Forecast by Type (2022-2027) & (US$/Unit)
Table 35. Global Subcutaneous Allergy Immunotherapies Sales by Application (2016-2021) & (K Units)
Table 36. Global Subcutaneous Allergy Immunotherapies Sales by Application (2022-2027) & (K Units)
Table 37. Global Subcutaneous Allergy Immunotherapies Sales Share by Application (2016-2021)
Table 38. Global Subcutaneous Allergy Immunotherapies Sales Share by Application (2022-2027)
Table 39. Global Subcutaneous Allergy Immunotherapies Revenue by Application (2016-2021) & (US$ Million)
Table 40. Global Subcutaneous Allergy Immunotherapies Revenue by Application (2022-2027) & (US$ Million)
Table 41. Global Subcutaneous Allergy Immunotherapies Revenue Share by Application (2016-2021)
Table 42. Global Subcutaneous Allergy Immunotherapies Revenue Share by Application (2022-2027)
Table 43. Subcutaneous Allergy Immunotherapies Price by Application (2016-2021) & (US$/Unit)
Table 44. Global Subcutaneous Allergy Immunotherapies Price Forecast by Application (2022-2027) & (US$/Unit)
Table 45. North America Subcutaneous Allergy Immunotherapies Sales by Type (2016-2021) & (K Units)
Table 46. North America Subcutaneous Allergy Immunotherapies Sales by Type (2022-2027) & (K Units)
Table 47. North America Subcutaneous Allergy Immunotherapies Revenue by Type (2016-2021) & (US$ Million)
Table 48. North America Subcutaneous Allergy Immunotherapies Revenue by Type (2022-2027) & (US$ Million)
Table 49. North America Subcutaneous Allergy Immunotherapies Sales by Application (2016-2021) & (K Units)
Table 50. North America Subcutaneous Allergy Immunotherapies Sales by Application (2022-2027) & (K Units)
Table 51. North America Subcutaneous Allergy Immunotherapies Revenue by Application (2016-2021) & (US$ Million)
Table 52. North America Subcutaneous Allergy Immunotherapies Revenue by Application (2022-2027) & (US$ Million)
Table 53. North America Subcutaneous Allergy Immunotherapies Sales by Country (2016-2021) & (K Units)
Table 54. North America Subcutaneous Allergy Immunotherapies Sales by Country (2022-2027) & (K Units)
Table 55. North America Subcutaneous Allergy Immunotherapies Revenue by Country (2016-2021) & (US$ Million)
Table 56. North America Subcutaneous Allergy Immunotherapies Revenue by Country (2022-2027) & (US$ Million)
Table 57. Europe Subcutaneous Allergy Immunotherapies Sales by Type (2016-2021) & (K Units)
Table 58. Europe Subcutaneous Allergy Immunotherapies Sales by Type (2022-2027) & (K Units)
Table 59. Europe Subcutaneous Allergy Immunotherapies Revenue by Type (2016-2021) & (US$ Million)
Table 60. Europe Subcutaneous Allergy Immunotherapies Revenue by Type (2022-2027) & (US$ Million)
Table 61. Europe Subcutaneous Allergy Immunotherapies Sales by Application (2016-2021) & (K Units)
Table 62. Europe Subcutaneous Allergy Immunotherapies Sales by Application (2022-2027) & (K Units)
Table 63. Europe Subcutaneous Allergy Immunotherapies Revenue by Application (2016-2021) & (US$ Million)
Table 64. Europe Subcutaneous Allergy Immunotherapies Revenue by Application (2022-2027) & (US$ Million)
Table 65. Europe Subcutaneous Allergy Immunotherapies Sales by Country (2016-2021) & (K Units)
Table 66. Europe Subcutaneous Allergy Immunotherapies Sales by Country (2022-2027) & (K Units)
Table 67. Europe Subcutaneous Allergy Immunotherapies Revenue by Country (2016-2021) & (US$ Million)
Table 68. Europe Subcutaneous Allergy Immunotherapies Revenue by Country (2022-2027) & (US$ Million)
Table 69. Asia Pacific Subcutaneous Allergy Immunotherapies Sales by Type (2016-2021) & (K Units)
Table 70. Asia Pacific Subcutaneous Allergy Immunotherapies Sales by Type (2022-2027) & (K Units)
Table 71. Asia Pacific Subcutaneous Allergy Immunotherapies Revenue by Type (2016-2021) & (US$ Million)
Table 72. Asia Pacific Subcutaneous Allergy Immunotherapies Revenue by Type (2022-2027) & (US$ Million)
Table 73. Asia Pacific Subcutaneous Allergy Immunotherapies Sales by Application (2016-2021) & (K Units)
Table 74. Asia Pacific Subcutaneous Allergy Immunotherapies Sales by Application (2022-2027) & (K Units)
Table 75. Asia Pacific Subcutaneous Allergy Immunotherapies Revenue by Application (2016-2021) & (US$ Million)
Table 76. Asia Pacific Subcutaneous Allergy Immunotherapies Revenue by Application (2022-2027) & (US$ Million)
Table 77. Asia Pacific Subcutaneous Allergy Immunotherapies Sales by Region (2016-2021) & (K Units)
Table 78. Asia Pacific Subcutaneous Allergy Immunotherapies Sales by Region (2022-2027) & (K Units)
Table 79. Asia Pacific Subcutaneous Allergy Immunotherapies Revenue by Region (2016-2021) & (US$ Million)
Table 80. Asia Pacific Subcutaneous Allergy Immunotherapies Revenue by Region (2022-2027) & (US$ Million)
Table 81. Latin America Subcutaneous Allergy Immunotherapies Sales by Type (2016-2021) & (K Units)
Table 82. Latin America Subcutaneous Allergy Immunotherapies Sales by Type (2022-2027) & (K Units)
Table 83. Latin America Subcutaneous Allergy Immunotherapies Revenue by Type (2016-2021) & (US$ Million)
Table 84. Latin America Subcutaneous Allergy Immunotherapies Revenue by Type (2022-2027) & (US$ Million)
Table 85. Latin America Subcutaneous Allergy Immunotherapies Sales by Application (2016-2021) & (K Units)
Table 86. Latin America Subcutaneous Allergy Immunotherapies Sales by Application (2022-2027) & (K Units)
Table 87. Latin America Subcutaneous Allergy Immunotherapies Revenue by Application (2016-2021) & (US$ Million)
Table 88. Latin America Subcutaneous Allergy Immunotherapies Revenue by Application (2022-2027) & (US$ Million)
Table 89. Latin America Subcutaneous Allergy Immunotherapies Sales by Country (2016-2021) & (K Units)
Table 90. Latin America Subcutaneous Allergy Immunotherapies Sales by Country (2022-2027) & (K Units)
Table 91. Latin America Subcutaneous Allergy Immunotherapies Revenue by Country (2016-2021) & (US$ Million)
Table 92. Latin America Subcutaneous Allergy Immunotherapies Revenue by Country (2022-2027) & (US$ Million)
Table 93. Middle East and Africa Subcutaneous Allergy Immunotherapies Sales by Type (2016-2021) & (K Units)
Table 94. Middle East and Africa Subcutaneous Allergy Immunotherapies Sales by Type (2022-2027) & (K Units)
Table 95. Middle East and Africa Subcutaneous Allergy Immunotherapies Revenue by Type (2016-2021) & (US$ Million)
Table 96. Middle East and Africa Subcutaneous Allergy Immunotherapies Revenue by Type (2022-2027) & (US$ Million)
Table 97. Middle East and Africa Subcutaneous Allergy Immunotherapies Sales by Application (2016-2021) & (K Units)
Table 98. Middle East and Africa Subcutaneous Allergy Immunotherapies Sales by Application (2022-2027) & (K Units)
Table 99. Middle East and Africa Subcutaneous Allergy Immunotherapies Revenue by Application (2016-2021) & (US$ Million)
Table 100. Middle East and Africa Subcutaneous Allergy Immunotherapies Revenue by Application (2022-2027) & (US$ Million)
Table 101. Middle East and Africa Subcutaneous Allergy Immunotherapies Sales by Country (2016-2021) & (K Units)
Table 102. Middle East and Africa Subcutaneous Allergy Immunotherapies Sales by Country (2022-2027) & (K Units)
Table 103. Middle East and Africa Subcutaneous Allergy Immunotherapies Revenue by Country (2016-2021) & (US$ Million)
Table 104. Middle East and Africa Subcutaneous Allergy Immunotherapies Revenue by Country (2022-2027) & (US$ Million)
Table 105. ALK-Abello Corporation Information
Table 106. ALK-Abello Description and Major Businesses
Table 107. ALK-Abello Subcutaneous Allergy Immunotherapies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 108. ALK-Abello Subcutaneous Allergy Immunotherapies Product
Table 109. ALK-Abello Recent Developments
Table 110. Stallergenes Greer Corporation Information
Table 111. Stallergenes Greer Description and Major Businesses
Table 112. Stallergenes Greer Subcutaneous Allergy Immunotherapies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 113. Stallergenes Greer Subcutaneous Allergy Immunotherapies Product
Table 114. Stallergenes Greer Recent Developments
Table 115. Merck Corporation Information
Table 116. Merck Description and Major Businesses
Table 117. Merck Subcutaneous Allergy Immunotherapies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 118. Merck Subcutaneous Allergy Immunotherapies Product
Table 119. Merck Recent Developments
Table 120. Allergy Therapeutics Corporation Information
Table 121. Allergy Therapeutics Description and Major Businesses
Table 122. Allergy Therapeutics Subcutaneous Allergy Immunotherapies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 123. Allergy Therapeutics Subcutaneous Allergy Immunotherapies Product
Table 124. Allergy Therapeutics Recent Developments
Table 125. HAL Corporation Information
Table 126. HAL Description and Major Businesses
Table 127. HAL Subcutaneous Allergy Immunotherapies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 128. HAL Subcutaneous Allergy Immunotherapies Product
Table 129. HAL Recent Developments
Table 130. WOLW Pharma Corporation Information
Table 131. WOLW Pharma Description and Major Businesses
Table 132. WOLW Pharma Subcutaneous Allergy Immunotherapies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 133. WOLW Pharma Subcutaneous Allergy Immunotherapies Product
Table 134. WOLW Pharma Recent Developments
Table 135. Holister Stier Corporation Information
Table 136. Holister Stier Description and Major Businesses
Table 137. Holister Stier Subcutaneous Allergy Immunotherapies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 138. Holister Stier Subcutaneous Allergy Immunotherapies Product
Table 139. Holister Stier Recent Developments
Table 140. Leti Corporation Information
Table 141. Leti Description and Major Businesses
Table 142. Leti Subcutaneous Allergy Immunotherapies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 143. Leti Subcutaneous Allergy Immunotherapies Product
Table 144. Leti Recent Developments
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Subcutaneous Allergy Immunotherapies Distributors List
Table 148. Subcutaneous Allergy Immunotherapies Customers List
Table 149. Subcutaneous Allergy Immunotherapies Market Trends
Table 150. Subcutaneous Allergy Immunotherapies Market Drivers
Table 151. Subcutaneous Allergy Immunotherapies Market Challenges
Table 152. Subcutaneous Allergy Immunotherapies Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Subcutaneous Allergy Immunotherapies Product Picture
Figure 2. Global Subcutaneous Allergy Immunotherapies Market Share by Type in 2020 & 2027
Figure 3. High Concentration Product Picture
Figure 4. Low Concentration Product Picture
Figure 5. Global Subcutaneous Allergy Immunotherapies Market Share by Application in 2020 & 2027
Figure 6. Primary Immunodeficiency
Figure 7. Secondary Immunodeficiency
Figure 8. Others
Figure 9. Subcutaneous Allergy Immunotherapies Report Years Considered
Figure 10. Global Subcutaneous Allergy Immunotherapies Sales 2016-2027 (K Units)
Figure 11. Global Subcutaneous Allergy Immunotherapies Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Subcutaneous Allergy Immunotherapies Revenue 2016-2027 (US$ Million)
Figure 13. Global Subcutaneous Allergy Immunotherapies Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 14. Global Subcutaneous Allergy Immunotherapies Sales Market Share by Region (2016-2021)
Figure 15. Global Subcutaneous Allergy Immunotherapies Sales Market Share by Region (2022-2027)
Figure 16. North America Subcutaneous Allergy Immunotherapies Sales YoY (2016-2027) & (K Units)
Figure 17. North America Subcutaneous Allergy Immunotherapies Revenue YoY (2016-2027) & (US$ Million)
Figure 18. Europe Subcutaneous Allergy Immunotherapies Sales YoY (2016-2027) & (K Units)
Figure 19. Europe Subcutaneous Allergy Immunotherapies Revenue YoY (2016-2027) & (US$ Million)
Figure 20. Asia-Pacific Subcutaneous Allergy Immunotherapies Sales YoY (2016-2027) & (K Units)
Figure 21. Asia-Pacific Subcutaneous Allergy Immunotherapies Revenue YoY (2016-2027) & (US$ Million)
Figure 22. Latin America Subcutaneous Allergy Immunotherapies Sales YoY (2016-2027) & (K Units)
Figure 23. Latin America Subcutaneous Allergy Immunotherapies Revenue YoY (2016-2027) & (US$ Million)
Figure 24. Middle East & Africa Subcutaneous Allergy Immunotherapies Sales YoY (2016-2027) & (K Units)
Figure 25. Middle East & Africa Subcutaneous Allergy Immunotherapies Revenue YoY (2016-2027) & (US$ Million)
Figure 26. The Top 10 and Top 5 Players Market Share by Subcutaneous Allergy Immunotherapies Sales in 2020
Figure 27. The Top 10 and Top 5 Players Market Share by Subcutaneous Allergy Immunotherapies Revenue in 2020
Figure 28. Subcutaneous Allergy Immunotherapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 29. Global Subcutaneous Allergy Immunotherapies Sales Market Share by Type (2016-2027)
Figure 30. Global Subcutaneous Allergy Immunotherapies Revenue Market Share by Type (2016-2027)
Figure 31. Global Subcutaneous Allergy Immunotherapies Sales Market Share by Application (2016-2027)
Figure 32. Global Subcutaneous Allergy Immunotherapies Revenue Market Share by Application (2016-2027)
Figure 33. North America Subcutaneous Allergy Immunotherapies Sales Market Share by Type (2016-2027)
Figure 34. North America Subcutaneous Allergy Immunotherapies Revenue Market Share by Type (2016-2027)
Figure 35. North America Subcutaneous Allergy Immunotherapies Sales Market Share by Application (2016-2027)
Figure 36. North America Subcutaneous Allergy Immunotherapies Revenue Market Share by Application (2016-2027)
Figure 37. North America Subcutaneous Allergy Immunotherapies Sales Share by Country (2016-2027)
Figure 38. North America Subcutaneous Allergy Immunotherapies Revenue Share by Country (2016-2027)
Figure 39. United States Subcutaneous Allergy Immunotherapies Revenue (2016-2027) & (US$ Million)
Figure 40. Canada Subcutaneous Allergy Immunotherapies Revenue (2016-2027) & (US$ Million)
Figure 41. Europe Subcutaneous Allergy Immunotherapies Sales Market Share by Type (2016-2027)
Figure 42. Europe Subcutaneous Allergy Immunotherapies Revenue Market Share by Type (2016-2027)
Figure 43. Europe Subcutaneous Allergy Immunotherapies Sales Market Share by Application (2016-2027)
Figure 44. Europe Subcutaneous Allergy Immunotherapies Revenue Market Share by Application (2016-2027)
Figure 45. Europe Subcutaneous Allergy Immunotherapies Sales Share by Country (2016-2027)
Figure 46. Europe Subcutaneous Allergy Immunotherapies Revenue Share by Country (2016-2027)
Figure 47. Germany Subcutaneous Allergy Immunotherapies Revenue (2016-2027) & (US$ Million)
Figure 48. France Subcutaneous Allergy Immunotherapies Revenue (2016-2027) & (US$ Million)
Figure 49. U.K. Subcutaneous Allergy Immunotherapies Revenue (2016-2027) & (US$ Million)
Figure 50. Italy Subcutaneous Allergy Immunotherapies Revenue (2016-2027) & (US$ Million)
Figure 51. Russia Subcutaneous Allergy Immunotherapies Revenue (2016-2027) & (US$ Million)
Figure 52. Asia Pacific Subcutaneous Allergy Immunotherapies Sales Market Share by Type (2016-2027)
Figure 53. Asia Pacific Subcutaneous Allergy Immunotherapies Revenue Market Share by Type (2016-2027)
Figure 54. Asia Pacific Subcutaneous Allergy Immunotherapies Sales Market Share by Application (2016-2027)
Figure 55. Asia Pacific Subcutaneous Allergy Immunotherapies Revenue Market Share by Application (2016-2027)
Figure 56. Asia Pacific Subcutaneous Allergy Immunotherapies Sales Share by Region (2016-2027)
Figure 57. Asia Pacific Subcutaneous Allergy Immunotherapies Revenue Share by Region (2016-2027)
Figure 58. China Subcutaneous Allergy Immunotherapies Revenue (2016-2027) & (US$ Million)
Figure 59. Japan Subcutaneous Allergy Immunotherapies Revenue (2016-2027) & (US$ Million)
Figure 60. South Korea Subcutaneous Allergy Immunotherapies Revenue (2016-2027) & (US$ Million)
Figure 61. India Subcutaneous Allergy Immunotherapies Revenue (2016-2027) & (US$ Million)
Figure 62. Australia Subcutaneous Allergy Immunotherapies Revenue (2016-2027) & (US$ Million)
Figure 63. Taiwan Subcutaneous Allergy Immunotherapies Revenue (2016-2027) & (US$ Million)
Figure 64. Indonesia Subcutaneous Allergy Immunotherapies Revenue (2016-2027) & (US$ Million)
Figure 65. Thailand Subcutaneous Allergy Immunotherapies Revenue (2016-2027) & (US$ Million)
Figure 66. Malaysia Subcutaneous Allergy Immunotherapies Revenue (2016-2027) & (US$ Million)
Figure 67. Latin America Subcutaneous Allergy Immunotherapies Sales Market Share by Type (2016-2027)
Figure 68. Latin America Subcutaneous Allergy Immunotherapies Revenue Market Share by Type (2016-2027)
Figure 69. Latin America Subcutaneous Allergy Immunotherapies Sales Market Share by Application (2016-2027)
Figure 70. Latin America Subcutaneous Allergy Immunotherapies Revenue Market Share by Application (2016-2027)
Figure 71. Latin America Subcutaneous Allergy Immunotherapies Sales Share by Country (2016-2027)
Figure 72. Latin America Subcutaneous Allergy Immunotherapies Revenue Share by Country (2016-2027)
Figure 73. Mexico Subcutaneous Allergy Immunotherapies Revenue (2016-2027) & (US$ Million)
Figure 74. Brazil Subcutaneous Allergy Immunotherapies Revenue (2016-2027) & (US$ Million)
Figure 75. Argentina Subcutaneous Allergy Immunotherapies Revenue (2016-2027) & (US$ Million)
Figure 76. Colombia Subcutaneous Allergy Immunotherapies Revenue (2016-2027) & (US$ Million)
Figure 77. Middle East and Africa Subcutaneous Allergy Immunotherapies Sales Market Share by Type (2016-2027)
Figure 78. Middle East and Africa Subcutaneous Allergy Immunotherapies Revenue Market Share by Type (2016-2027)
Figure 79. Middle East and Africa Subcutaneous Allergy Immunotherapies Sales Market Share by Application (2016-2027)
Figure 80. Middle East and Africa Subcutaneous Allergy Immunotherapies Revenue Market Share by Application (2016-2027)
Figure 81. Middle East and Africa Subcutaneous Allergy Immunotherapies Sales Share by Country (2016-2027)
Figure 82. Middle East and Africa Subcutaneous Allergy Immunotherapies Revenue Share by Country (2016-2027)
Figure 83. Turkey Subcutaneous Allergy Immunotherapies Revenue (2016-2027) & (US$ Million)
Figure 84. Saudi Arabia Subcutaneous Allergy Immunotherapies Revenue (2016-2027) & (US$ Million)
Figure 85. UAE Subcutaneous Allergy Immunotherapies Revenue (2016-2027) & (US$ Million)
Figure 86. Subcutaneous Allergy Immunotherapies Value Chain
Figure 87. Subcutaneous Allergy Immunotherapies Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed


【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[世界の皮下アレルギー免疫療法市場インサイト・予測(~2027)] (Global Subcutaneous Allergy Immunotherapies Market Insights and Forecast to 2027 / QYR21DC05573)についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆